Fortis Healthcare — Legal Setback, But No Fundamental Change: ICICI Securities
The Supreme Court of India has announced its judgement in the Daiichi Sankyo-Fortis-IHH case.
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
The Supreme Court of India has announced its judgement in the Daiichi Sankyo-Fortis-IHH case. Excerpts from the judgement:
stay order on the open offer of 26% post Fortis-IHH deal in FY19 continues;
pronounces jail term of six months for the Singh brothers;
remands the issue to Delhi High Court; and
directs Delhi HC to consider a forensic audit for the Fortis-IHH deal.
Fortis will seek legal advice on the matter. As legal battle ensues, IHH remains the majority stakeholder (~31%) of Fortis and shall continue to operate the business as usual. Hence, we believe the stock holds fundamental value with recovery in growth, cost optimisation and potential for operating leverage in both its verticals (hospitals and diagnostics).
Click on the attachment to read the full report:
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.